Stay updated with breaking news from Immuron Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Globally integrated biopharmaceuticals company Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has had a bumper year for its over-the-counter gastrointestinal and...
The Board of Directors of Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has given the green light for the company to proceed with IMM-529 cGMP manufacturing for the...
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has received US Army Medical Research and Development Command (USAMRDC) Office of Human and Animal Research Oversight...
The ASX drove higher today, with the S&P/ASX200 gaining 52.50 points or 0.73% to 7,272.50 and crossing above its 125-day moving average. Over the last five...
Immuron Ltd (NASDAQ:IMRN, ASX:IMC), an immunotherapy-focused biopharmaceutical company based in Australia, is readying to proceed with clinical evaluation...